Related Experiment Video
Updated: Feb 16, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Neonatal fatty acid status and neurodevelopmental outcome at 9 years
Corina de Jong1, Hedwig K Kikkert2, Jorien Seggers2
1University of Groningen, University Medical Center Groningen, Department of General Practice, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Paediatrics, Institute of Developmental Neurology, Groningen, The Netherlands.
Insights
Higher umbilical docosahexaenoic acid (DHA) in infant boys is linked to better neurological development by age 9. Neonatal arachidonic acid (AA) status did not show a significant association with neurodevelopmental outcomes.
Area of Science:
- Neuroscience
- Developmental Biology
- Nutritional Science
Background:
- Long-chain polyunsaturated fatty acids (LCPUFA) are crucial for prenatal brain development.
- Previous research on LCPUFA and neurodevelopment has yielded debated findings, with outcomes typically assessed up to age 7.
- The long-term impact of neonatal LCPUFA status on development remains an area of investigation.
Purpose of the Study:
- To examine the association between fatty acid status at birth and neurodevelopmental outcomes at 9 years of age.
- To investigate the relationship between neonatal docosahexaenoic acid (DHA) and arachidonic acid (AA) levels and neurological, cognitive, and behavioral development.
- To assess neurodevelopmental outcomes at age 9, a period following significant developmental transitions.
Main Methods:
- A correlational study design was employed, analyzing data from 235 children (74% of 317 eligible) reassessed at age 9.
- Neonatal DHA and AA levels were measured in the umbilical vein wall.
- Multivariable analyses were conducted to adjust for potential confounding factors, focusing on minor neurological dysfunction (cMND), cognitive (IQ), and behavioral outcomes.
Main Results:
- Boys with complex minor neurological dysfunction (cMND) exhibited lower umbilical DHA levels compared to those with better neurological status (p=0.033).
- This association between DHA and neurological status was not observed in girls.
- Neonatal AA levels were not significantly associated with neurological, cognitive, or behavioral outcomes at age 9.
Conclusions:
- Elevated umbilical cord DHA levels in male infants are associated with improved neurological development by age 9.
- Neonatal AA status at birth does not appear to be associated with neurodevelopmental outcomes at 9 years.
- The findings highlight a potential sex-specific role for DHA in long-term neurodevelopment.
Background:
Long-chain polyunsaturated fatty acids (LCPUFA) are important for prenatal brain development. Previous studies of others assessed outcome until 7 years. The associations between neonatal LCPUFA status and long-term developmental outcome are debated.
Aim:
To investigate the relationship between fatty acid status at birth and neurodevelopment at 9 years. Age 9 is a unique age after a significant neurodevelopmental transition.
Study Design:
Correlation study. Multivariable analyses were carried out to adjust for potential confounders.
Subjects:
317 children who participated in a trial on effects of postnatal LCPUFA supplementation were eligible. 235 children (74%) were reassessed at age 9.
Outcome Measures:
At birth, docosahexaenoic acid (DHA) and arachidonic acid (AA) were determined in the wall of the umbilical vein. We primarily studied the correlation between DHA and AA with the complex form of minor neurological dysfunction (cMND). Secondary correlations that were studied were DHA and AA levels with cognitive development in terms of full IQ, and with behavioural development in terms of a total problem score.
Results:
Boys with cMND showed lower DHA values in the umbilical vein than children with better neurological condition (p=0.033). A similar association was absent in girls. Neonatal AA values were not associated with neurological outcome. Neither neonatal DHA nor AA values were associated with cognition and behaviour at 9.
Conclusions:
Higher umbilical DHA levels in boys are associated with better neurological development at 9 years. AA status at birth was not associated with neurodevelopment at 9 years.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Marcia's Theory of Identity Status
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Amino acids

